Clinical Impact of in Children with Cystic Fibrosis

Overview

Journal Microorganisms

Specialty Microbiology

Date 2022 Apr 23

PMID 35456789

Authors

Valentina Fainardi

Chiara Sodini

Michela Deolmi

Andrea Ciuni

Kaltra Skenderaj

Maria Bice Stabile

Cosimo Neglia

Elena Mariotti Zani

Cinzia Spaggiari

Nicola Sverzellati

Susanna Esposito

Giovanna Pisi

Affiliations

Soon will be listed here.

Abstract

Background. The clinical relevance of Aspergillus fumigatus (Af) in cystic fibrosis (CF) is controversial. The aims of the study were to assess the prevalence of Af disease in our cohort of CF patients and evaluate whether allergic bronchopulmonary aspergillosis (ABPA) and sensitization to Af affected lung function, body mass index (BMI) and exacerbations. Methods. Clinical data and lung function of CF patients aged 6−18 years followed at the CF Centre of Parma (Italy) were recorded. Patients were classified as: patients with no signs of Af, patients sensitized or colonized by Af, patients with ABPA or patients with Aspergillus bronchitis (Ab). Results. Of 38 CF patients (14.2 years (6.2−18.8) M 23), 8 (21%) showed Af sensitization, 7 (18.4%) showed ABPA, 1 (2.6%) showed Af colonization and 1 (2.6%) showed Ab. Compared to non-ABPA, patients with ABPA had lower BMI (15.9 ± 1.6 vs. 19.7 ± 3.4, p < 0.005), lower lung function (FEV1 61.5 ± 25.9% vs. 92.3 ± 19.3%, p < 0.001) and more exacerbations/year (4.43 ± 2.44 vs. 1.74 ± 2.33, p < 0.005). Patients with Af sensitization showed more exacerbations/year than non-Af patients (3.5 ± 3.2 vs. 0.9 ± 1.2, p < 0.005). ABPA and sensitized patients had more abnormalities on chest CT scans. Conclusion. This study showed the relevant clinical impact of ABPA and Af sensitization in terms of exacerbations and lung structural damage.

Citing Articles

Effect of yeast probiotic cell wall extract on allergenicity in A549 cells.

Nikaein D, Malekmadani H, Beikzadeh B, Mardanpour R, Khosravi A, Moghadami S Curr Med Mycol. 2024; 9(4):1-8.

PMID: 38983617 PMC: 11230140. DOI: 10.22034/cmm.2024.345134.1463.

References

King J, Brunel S, Warris A . Aspergillus infections in cystic fibrosis. J Infect. 2016; 72 Suppl:S50-5. DOI: 10.1016/j.jinf.2016.04.022. View

Foster K, Alton H . Chronic lung infection in children. Paediatr Respir Rev. 2003; 4(3):225-9. View

Kidd T, Canton R, Ekkelenkamp M, Krogh Johansen H, Gilligan P, LiPuma J . Defining antimicrobial resistance in cystic fibrosis. J Cyst Fibros. 2018; 17(6):696-704. DOI: 10.1016/j.jcf.2018.08.014. View

Kaditis A, Miligkos M, Bossi A, Colombo C, Hatziagorou E, Kashirskaya N . Effect of allergic bronchopulmonary aspergillosis on FEV in children and adolescents with cystic fibrosis: a European Cystic Fibrosis Society Patient Registry analysis. Arch Dis Child. 2017; 102(8):742-747. DOI: 10.1136/archdischild-2016-311132. View

Nikolaizik W, Crameri R, Blaser K, Schoni M . Skin test reactivity to recombinant Aspergillus fumigatus allergen I/a in patients with cystic fibrosis. Int Arch Allergy Immunol. 1996; 111(4):403-8. DOI: 10.1159/000237399. View

Breuer O, Schultz A, Garratt L, Turkovic L, Rosenow T, Murray C . Infections and Progression of Structural Lung Disease in Children with Cystic Fibrosis. Am J Respir Crit Care Med. 2019; 201(6):688-696. DOI: 10.1164/rccm.201908-1585OC. View

De Baets F, De Keyzer L, Van Daele S, Schelstraete P, Van Biervliet S, Van Braeckel E . Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients. Pediatr Allergy Immunol. 2018; 29(7):726-731. DOI: 10.1111/pai.12953. View

Tiddens H, Rosenow T . What did we learn from two decades of chest computed tomography in cystic fibrosis?. Pediatr Radiol. 2014; 44(12):1490-5. DOI: 10.1007/s00247-014-2964-6. View

Gothe F, Kappler M, Griese M . Increasing Total Serum IgE, Allergic Bronchopulmonary Aspergillosis, and Lung Function in Cystic Fibrosis. J Allergy Clin Immunol Pract. 2017; 5(6):1591-1598.e6. DOI: 10.1016/j.jaip.2017.03.033. View

10.

Mastella G, Rainisio M, Harms H, Hodson M, Koch C, Navarro J . Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J. 2000; 16(3):464-71. DOI: 10.1034/j.1399-3003.2000.016003464.x. View

11.

Frauchiger B, Binggeli S, Yammine S, Spycher B, Kruger L, Ramsey K . Longitudinal course of clinical lung clearance index in children with cystic fibrosis. Eur Respir J. 2020; 58(1). DOI: 10.1183/13993003.02686-2020. View

12.

Poore T, Meier M, Towler E, Martiniano S, Brinton J, DeBoer E . Clinical characteristics of people with cystic fibrosis and frequent fungal infection. Pediatr Pulmonol. 2021; 57(1):152-161. PMC: 8665034. DOI: 10.1002/ppul.25741. View

13.

Quanjer P, Stanojevic S, Cole T, Baur X, Hall G, Culver B . Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012; 40(6):1324-43. PMC: 3786581. DOI: 10.1183/09031936.00080312. View

14.

Reece E, Segurado R, Jackson A, McClean S, Renwick J, Greally P . Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis. BMC Pulm Med. 2017; 17(1):70. PMC: 5401475. DOI: 10.1186/s12890-017-0416-4. View

15.

Brody A . Scoring systems for CT in cystic fibrosis: who cares?. Radiology. 2004; 231(2):296-8. DOI: 10.1148/radiol.2312032097. View

16.

Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman B, McCauley D . Cystic fibrosis: scoring system with thin-section CT. Radiology. 1991; 179(3):783-8. DOI: 10.1148/radiology.179.3.2027992. View

17.

McMahon M, Chotirmall S, McCullagh B, Branagan P, McElvaney N, Logan P . Radiological abnormalities associated with Aspergillus colonization in a cystic fibrosis population. Eur J Radiol. 2011; 81(3):e197-202. DOI: 10.1016/j.ejrad.2011.01.114. View

18.

Nguyen L, Viscogliosi E, Delhaes L . The lung mycobiome: an emerging field of the human respiratory microbiome. Front Microbiol. 2015; 6:89. PMC: 4327734. DOI: 10.3389/fmicb.2015.00089. View

19.

BECKER J, Burke W, McDonald G, Greenberger P, Henderson W, Aitken M . Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis. Chest. 1996; 109(6):1536-40. DOI: 10.1378/chest.109.6.1536. View

20.

Saunders R, Modha D, Claydon A, Gaillard E . Chronic Aspergillus fumigatus colonization of the pediatric cystic fibrosis airway is common and may be associated with a more rapid decline in lung function. Med Mycol. 2016; 54(5):537-43. DOI: 10.1093/mmy/myv119. View